
|Videos|November 5, 2018
Immunotherapy Potential in Locally Advanced CSCC
Immunotherapy Potential in Locally Advanced CSCC
Advertisement
A 69-Year-Old Man With Advanced CSCC
- History and physical exam
- An otherwise healthy, 69-year-old male, fair skinned, retired construction worker, widow
- Presented to his PCP with what he described as a wound that was not healing behind his ear; he reported first noticing it at least 6 months ago and complained of recent onset of numbness in the area.
- ECOG PS 1
- The visible, ulcerated lesion was 4.5-cm in diameter and >5-mm deep
- No palpable nodes
- Biopsy confirmed a poorly-differentiated, infiltrative, postauricular cutaneous squamous cell carcinoma lesion with 7-mm invasion into subcutaneous fat.
- The recommended definitive surgical approach involved partial auriculectomy; the patient declined.
- Cemiplimab 3 mg/kg q2w was initiated
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Approves Iberdomide, the First CELMoD for Relapsed/Refractory Multiple Myeloma
2
AMH Testing Predicts Chemotherapy Benefit in RxPONDER Breast Cancer
3
ASTRO Issues Updated Clinical Practice Guideline on RT for Pancreatic Cancer
4
FAQ: When and How to Discontinue Lenalidomide Maintenance in Multiple Myeloma
5


































